Aromasin
Developed to target oestrogen production and indicated to support cancer treatment, this inhibitor is utilized to address hormone-sensitive malignancies.
- Categories
- Oncology Support · Pct & Men's Fitness
- Active ingredient
- Exemestane
- Supply
- Rx
- Route
- Oral use
- Form
- Tablet
- Strengths
- 25mg
Aromasin details
- Condition
- Breast Cancer
- Therapeutic class
- Aromatase inhibitor
- Pharmacological class
- Steroidal aromatase inactivator
- Minor side effects
- hot flushes; fatigue; nausea
- Moderate side effects
- insomnia; arthralgia; alopecia
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription only (specially controlled medicine)
- Manufacturer
- Pfizer
- Onset Time
- 2–3 days
- Duration
- daily
- Storage instructions
- Store at room temperature, out of reach of children.
- Drug interactions
- oestrogen-containing therapies; st. john's wort
- Age restrictions
- Not for children.
- Pregnancy and breastfeeding
- Pregnancy: Contraindicated. Breastfeeding: Do not use.
Contraindications
pre-menopausal endocrine status; hypersensitivity to exemestane; severe renal impairment; severe hepatic impairment
Precautions and warnings
monitor bone mineral density; regular blood monitoring required; not for pre-menopausal women
Serious side effects
osteoporosis, requires immediate medical attention; pathological fractures, requires immediate medical attention; severe hepatitis, requires immediate medical attention
Patient summary
Developed to target oestrogen production and indicated to support cancer treatment, this inhibitor is utilized to address hormone-sensitive malignancies.
Mechanism of action
Exemestane is a steroidal aromatase inactivator that prevents the conversion of androgens into oestrogens in peripheral tissues. By reducing circulating oestrogen levels, it inhibits the growth of hormone-dependent breast carcinoma.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Aromasin
Aromasin contains exemestane, an aromatase inhibitor used in the treatment of breast cancer. Manufactured by Pfizer, this medication works by lowering oestrogen levels in the body. It is supplied as a 25mg tablet. This therapy is intended for use under the guidance and monitoring of a medical professional.
Aromasin availability in Asia
Aromasin is registered across 14 markets including Hong Kong, Thailand and Malaysia, with availability also in the Philippines, Indonesia and Taiwan. Access to this medication can be challenging for those living in or travelling through the region, particularly when local inventory is inconsistent. Patients finding it difficult to source exemestane locally are encouraged to ensure they maintain continuous support through their primary oncology team.